Acusphere, Inc. operates as a specialty pharmaceutical company that develops and commercializes cardiovascular drugs. It offers Imagify (perflubutane polymer microspheres), a cardiovascular drug that evaluates myocardial perfusion and detects coronary artery disease. It provides Imagify as an injectable suspension. The company was formerly known as Polymers For Medicine, Inc. and changed its name to Acusphere, Inc. in March 2004. Acusphere, Inc. was founded in 1993 and is based in Watertown, Massachusetts.
Frequently asked questions
What sector does Acusphere Inc (ACUS) operate in?
Acusphere Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Acusphere Inc (ACUS) current stock price?
As of the latest data, Acusphere Inc stock price is $0.00, with a previous close of $0.00.
What is Acusphere Inc (ACUS) current market capitalization?
Acusphere Inc market cap is approximately 3.71 million.
Does Acusphere Inc (ACUS) pay dividends?
No. Acusphere Inc does not pay a dividend.
What is Acusphere Inc (ACUS) beta (volatility) score?
Acusphere Inc has a beta of -0.329, indicating lower volatility than the overall market.